Accession Number : AD1014847

Title :   DNA Damage and Oxidative Stress in Dyskeratosis Congenita: Analysis of Pathways and Therapeutic Stategies Using CPISPR and iPSC Model Systems

Descriptive Note : Technical Report,01 Jun 2015,31 May 2016

Corporate Author : University of Alabama at Birmingham Birmingham United States

Personal Author(s) : Goldman,Frederick ; Westin,Erik

Full Text :

Report Date : 01 Jun 2016

Pagination or Media Count : 13

Abstract : Dyskeratosis congenita is a disorder that arises due to prematurely shortened telomeres and characterized by a classical clinical triad of leukoplakia, skin dyspigmentation and nail dystrophy with concomitant marrow failure. DC symptomology, to a degree, corresponds to critically shortened telomeres that limits cellular replicative potential and thus prematurely exhausts stem cell pools. Our previous findings support a hypothesis whereby shortened telomeres increase DNA damage responses within the cell leading to heightened reactive oxygen species (ROS). Recent work supported under this research grant have uncovered a suppressed steady-state RNA expression and protein levels of the NRF2 and NRF3 pathways within DC skin fibroblasts. This suppression is also found in cells exposed to an environment with experimentally-elevated oxidative stress. Furthermore, preliminary RNA-Seq experiments suggest that senescence associated secretory pathway (SASP) is altered in DC cells and suppressed upon mobilization of telomerase. Finally, decreased oxidative stress levels could be found in DC cells upon forced expression of an NRF2 heterodimerizing protein, MAFG, suggesting that suppression of this pathway yields to an unmitigated increase in ROS. Together, these findings provide support for a mechanism whereby shortened telomeres mobilize a DNA damage response that in turn suppresses antioxidant proteins leading to an increase in oxidative stress.

Descriptors :   Bone marrow , Aging(Physiology) , stem cells , cell physiological processes , cell division , gene expression

Distribution Statement : APPROVED FOR PUBLIC RELEASE